Clinical Trials Browser

Phase 1 × Neurologic Manifestations × Bevacizumab × Clear all

NCT02313272 2023-10-23

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Phase 1 Completed

32 enrolled 12 charts

Glioma, Neoplasms, Neurologic Manifestations

NCT00762255 2013-07-25

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Phase 1 Completed

Glioblastoma, Neurologic Manifestations